Cenobamate: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 11:5111:51, 13 April 2025 Omid Afkhami-Ardakani talk contribs 7,196 bytes +7,196 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=cenobamate |aOrAn=a |drugClass=Sodium Channel Inhibitor |indicationType=treatment |indication=partial-onset seizures in adult patients. |adverseReactions=dizziness, somnolence, fatigue, headache, nausea, constipation, balance disorder, and rash. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content..."